Correlation Between Haemonetics and 784730AB9

Can any of the company-specific risk be diversified away by investing in both Haemonetics and 784730AB9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haemonetics and 784730AB9 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Haemonetics and US784730AB94, you can compare the effects of market volatilities on Haemonetics and 784730AB9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haemonetics with a short position of 784730AB9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haemonetics and 784730AB9.

Diversification Opportunities for Haemonetics and 784730AB9

-0.74

Correlation Coefficient

Haemonetics  784730AB9

Pay attention - limited upside

The 3 months correlation between Haemonetics and 784730AB9 is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Haemonetics and US784730AB94 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US784730AB94 and Haemonetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haemonetics are associated (or correlated) with 784730AB9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US784730AB94 has no effect on the direction of Haemonetics i.e., Haemonetics and 784730AB9 go up and down completely randomly.

Pair Corralation between Haemonetics and 784730AB9

Considering the 90-day investment horizon Haemonetics is expected to under-perform the 784730AB9. In addition to that, Haemonetics is 2.43 times more volatile than US784730AB94. It trades about -0.12 of its total potential returns per unit of risk. US784730AB94 is currently generating about 0.6 per unit of volatility. If you would invest  9,615  in US784730AB94 on December 26, 2024 and sell it today you would earn a total of  890.00  from holding US784730AB94 or generate 9.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	22.95%
Values	Daily Returns

Haemonetics  vs.  US784730AB94

Haemonetics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Haemonetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

US784730AB94

Risk-Adjusted Performance

Excellent

Compared to the overall equity markets, risk-adjusted returns on investments in US784730AB94 are ranked lower than 47 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, 784730AB9 sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Haemonetics and 784730AB9

The main advantage of trading using opposite Haemonetics and 784730AB9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haemonetics position performs unexpectedly, 784730AB9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 784730AB9 will offset losses from the drop in 784730AB9's long position.

The idea behind Haemonetics and US784730AB94 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.